Education
About Us
Working with TipRanks
Follow Us
Living Cell Technologies Ltd. (AU:1AI)
ASX:1AI
1AI Stock Chart & Stats
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.01
Previous CloseN/A
Volume31.97M
Average Volume (3M)1.91M
Market Cap
$8.44M
Enterprise ValueAU$13.77M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)0.00
Price to Earnings (P/E)―
Beta-0.13
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding1,687,394,800
10 Day Avg. Volume3,685,190
30 Day Avg. Volume1,911,646
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3066.44
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Living Cell Technologies Ltd. News
PremiumCompany Announcements
Algorae Pharmaceuticals Reports Reduced Losses and Advances AI Drug Discovery
PremiumCompany Announcements
Algorae Pharmaceuticals’ AI-168 Shows Promising Results
PremiumCompany Announcements
Algorae Pharmaceuticals Strengthens Board with Industry Expert
PremiumCompany Announcements
Algorae Pharmaceuticals Expands Pipeline with AI-Driven Targets
PremiumCompany Announcements
Algorae Pharmaceuticals Plans Major Securities Issuance
PremiumCompany Announcements
Algorae Pharmaceuticals Streamlines Operations with OTCQB Exit---
1AI FAQ
What was Living Cell Technologies Ltd.’s price range in the past 12 months?
Living Cell Technologies Ltd. lowest share price was <AU$0.01 and its highest was AU$0.01 in the past 12 months.
What is Living Cell Technologies Ltd.’s market cap?
Living Cell Technologies Ltd.’s market cap is $8.44M.
When is Living Cell Technologies Ltd.’s upcoming earnings report date?
Living Cell Technologies Ltd.’s upcoming earnings report date is Aug 27, 2025 which is in 145 days.
How were Living Cell Technologies Ltd.’s earnings last quarter?
Living Cell Technologies Ltd. released its earnings results on Feb 26, 2025. The company reported AU$0 earnings per share for the quarter, the consensus estimate of N/A by AU$0.
Is Living Cell Technologies Ltd. overvalued?
According to Wall Street analysts Living Cell Technologies Ltd.’s price is currently Overvalued.
Does Living Cell Technologies Ltd. pay dividends?
Living Cell Technologies Ltd. does not currently pay dividends.
What is Living Cell Technologies Ltd.’s EPS estimate?
Living Cell Technologies Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Living Cell Technologies Ltd. have?
Living Cell Technologies Ltd. has 1,687,394,800 shares outstanding.
What happened to Living Cell Technologies Ltd.’s price movement after its last earnings report?
Living Cell Technologies Ltd. reported an EPS of AU$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -9.091%.
Which hedge fund is a major shareholder of Living Cell Technologies Ltd.?
Currently, no hedge funds are holding shares in AU:1AI
---
Living Cell Technologies Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:1AI Sentiment 100%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-43.32%
Trailing 12-Months
Asset Growth
-38.77%
Trailing 12-Months
Company Description
Living Cell Technologies Ltd.
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.
---
Mesoblast Limited
―
Orthocell Ltd
―
PYC Therapeutics Limited
―
Recce Pharmaceuticals Ltd.
―
---